Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 5.72M | $181.0M | 11.11% | +1.02M | 2026-06-30 |
| RTW INVESTMENTS, LP | 4.87M | $154.0M | 9.46% | -- | 2026-06-30 |
| FMR LLC | 4.31M | $136.0M | 8.37% | -521.9K | 2026-06-30 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.64M | $115.0M | 7.07% | -55.0K | 2026-06-30 |
| Bellevue Group AG | 2.79M | $88.0M | 5.42% | -8.6K | 2026-06-30 |
| TANG CAPITAL MANAGEMENT LLC | 2.65M | $84.0M | 5.15% | -- | 2026-06-30 |
| Vestal Point Capital, LP | 1.80M | $57.0M | 3.50% | -966.9K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.65M | $52.0M | 3.20% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 1.60M | $50.0M | 3.10% | +359.6K | 2026-06-30 |
| ARMISTICE CAPITAL, LLC | 1.43M | $45.0M | 2.77% | +240.0K | 2026-06-30 |
